Navigation Links
Genuine Bio-Fuel Inc. Expands Operations to Puerto Rico
Date:12/12/2012

Indiantown, FL (PRWEB) December 12, 2012

Genuine Bio-Fuel Inc. (GBF), headquartered in Indiantown, Florida expands its operations to the northeastern Caribbean region with the development of new subsidiary Caribbean Bio-Fuel, Inc. (CBF). The new company will be based in Puerto Rico and service Caribbean and South American markets.

These emerging markets will be able to capitalize on GBF’s proprietary technology, which allows it to reduce the biodiesel production time from hours to mere seconds — without creating any hazardous by-products in the process. Executive Vice President Jeff Longo noted the Caribbean Bio-Fuel plant would have the capacity to produce about twelve million gallons of biodiesel per year.

The new 35,000 square foot facility is slated to open March 2013 and will employ approximately twelve to eighteen people at launch. The raw materials and multi-feedstocks will come from Puerto Rico and surrounding islands. Executive Vice President Jeff Longo expressed, “This is an exciting time for Genuine Bio-Fuel. This expansion will allows us to be a global competitor in the alternative energy industry, but our mission will ultimately remain the same. With Caribbean Bio-Fuel we strive to build an environmentally responsible facility, create jobs, and help spur economic growth in this region.” Longo also looks forward to developing other co-products unique to this region.

More about Genuine Bio-Fuel: Genuine Bio-Fuel Inc. is a leader in biodiesel production and technology in Florida. Working with local communities since 2008, they collect used vegetable cooking oil, plant oils and fats, refine it and efficiently produce renewable, sustainable clean biodiesel that meets or exceeds the required ASTM standards. An RFS-2 Registered Renewable Fuel Producer, this dedicated environmental steward is 100% privately funded.

To find more information about the development of the Caribbean Bio-Fuel please contact Jeff Longo by phone toll free 866-268-7885, or via email at gbf(at)genuinebiofuel(dot)com.

To find out more about Genuine Bio-Fuel’s please visit our website http://www.genuinebiofuel.com/.

Read the full story at http://www.prweb.com/releases/GenuineBioFuel/CaribPlant/prweb10230355.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Rhythm Expands Series B Financing to $33 Million; Adds Pfizer Ventures as an Investor
2. H3 Biomedicine Expands Cambridge Facilities, Doubles Employee Base as Scientific Program Advances
3. Medical Marijuana, Inc. Portfolio Company CanChew BioTechnologies Inc. Updates and Expands Free Product Trial
4. Why Texas is #1 in Business: Local BioTech Company Expands
5. Ceres Expands Board of Directors with former BP Chief Scientist and Undersecretary of Energy Steven Koonin
6. Rosetta Genomics Expands Management Team, Laboratory Capacities and Commercial Operations
7. Elsevier Expands Access to Digital Offerings Through Collaboration with Follett
8. BioStorage Technologies Expands its Service Offering to Include Advanced Bioprocessing Solutions
9. Celltex Therapeutics Corporation Expands Laboratory Operations And Adds Depth To Its Management Team
10. Inspiration Biopharmaceuticals Expands Industry Expertise with Five New Executive Hires
11. Medtech Expands Nursing Education Opportunities In Florida
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... HACKENSACK, N.J. , Feb. 16, 2017  Champions ... engaged in the development and sale of advanced technology ... of oncology drugs, today announced the addition of new ... These new models will expand Champions, product ... cancer, head and neck cancer, AML, and non-small cell ...
(Date:2/16/2017)... and NEW YORK , Feb. 16, ... completion of their $7M Series B financing, adding an ... the $3.5M led by Mesa Verde Venture Partners and ... resources will be directed towards further accelerating commercial adoption ... comprehensive genomic profiling test and expanding the Paradigm cancer ...
(Date:2/15/2017)... , 15. Februar 2017  Trianni, Inc. ... Biotech, Inc. (Janssen) eine Lizenzvereinbarung über die Verwendung ... Klasse führenden Plattform für die Entdeckung monoklonaler Antikörper. ... ihr neuartiges chimäres Gensegmentdesign aus, das Janssen ... humanen Antikörpern bietet und das für die schelle ...
(Date:2/15/2017)... -- Windtree Therapeutics, Inc. (Nasdaq: WINT ), ... therapies for respiratory diseases, will host a conference call ... EST on Thursday, February 16, 2017 to provide updates ... announced closing of a $10.5 million private offering and ... in the live call and take part in the ...
Breaking Biology Technology:
(Date:2/2/2017)... JACKSONVILLE, Fla. , Feb. 2, 2017 /PRNewswire/ ... ), a clinical-stage immuno-oncology company specializing in the ... vaccines for the treatment of cancer and metastatic ... multi-gram scale-up and GMP manufacturing of a second ... T-cell vaccine targeting folate receptor alpha. The manufactured ...
(Date:2/2/2017)... , Feb. 1, 2017  Central to its ... meaningful advances worldwide, The Japan Prize Foundation today ... who have pushed the envelope in their respective ... Communication. Three scientists are being recognized with the ... that not only contribute to the advancement of ...
(Date:1/31/2017)... Jan. 31, 2017  Spero Therapeutics, LLC, a ... the treatment of bacterial infections, today announced it ... candidates from Pro Bono Bio Ltd (PBB) to ... multi-drug resistant forms of Gram-negative bacteria.   The assets ... Ltd, a PBB group company. "The ...
Breaking Biology News(10 mins):